点击图片查看原图
中文名称：替格瑞洛杂质，替卡格雷杂质对照品
英文名称：Ticagrelor Impurity
规格：10mg/25mg/50mg/100mg等多种规格可选。
用途：实验研发，药品申报检测，不得用于临床医学诊断。
随货提供：所有杂质对照品均随货提供HPLC，NMR，MS图谱及CoA证书。
保存及取用：为了防止产品含量降低，应防潮，避光和抗氧化包装，保存应以提高物质稳定性为原则。如果一次使用很少量，可以将其适当分装后使用，这样可以有效的防止试剂污染。请不要在脏乱和强光环境中取用，以免造成污染和失效。
替格瑞洛杂质，替卡格雷杂质对照品 杂质列表：
| Ticagrelor | (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 1 | (1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 2 | (1S,2S,3R,5S)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 3 | (1R,2R,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 4（Mixture of Diastereomers） | (1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1S,2S,3R,5S)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1) |
| Ticagrelor Impurity 5（Mixture of Diastereomers） | (1R,2R,3S,5R)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol compound with (1R,2R,3S,5R)-3-(7-(((1S,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol (1:1) |
| Ticagrelor Impurity 6 | 2-(((1S,2S,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,3-dihydroxycyclopentyl)oxy)ethyl acetate |
| Ticagrelor Impurity 7 | (1S,2S,3R,5S)-3-(7-hydroxy-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 8 | (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(4-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 9 | 2-(((3aR,4S,6R,6aS)-6-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
| Ticagrelor Impurity 10 | 5-amino-6-chloro-2-(propylthio)pyrimidin-4-ol |
| Ticagrelor Impurity 11 | 2-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)oxy)ethanol |
| Ticagrelor Impurity 12 | (1S,2S,3R,5S)-3-((5-amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 13 | 5-amino-6-(((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)amino)-2-(propylthio)pyrimidin-4-ol |
| Ticagrelor Impurity 14 | (1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3-fluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 15 | (1S,2S,3R,5S)-3-(7-(((1R,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-methoxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 16 | 2-(((3aS,4R,6S,6aR)-6-((3-((3aS,4R,6S,6aR)-6-(2-hydroxyethoxy)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
| Ticagrelor Impurity 17 | (1R,2R,3S,5R)-3-((3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 18 | (1S,2S,3R,5S)-3-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 19 | (1S,2S,3R,5S)-3-((3-((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-yl)amino)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 20 | (1S,2R,3S,4R)-4-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2,3-triol |
| Ticagrelor Impurity 21 | (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 22 | (1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 23 | sodium 7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-3-((1R,2S,3S,4S)-2,3-dihydroxy-4-(2-hydroxyethoxy)cyclopentyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-olate |
| Ticagrelor Impurity 24 | (1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfinyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 25 | (1S,2S,3S,5R)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfonyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 26 | 2-((6-chloro-5-(7-(2-hydroxyethoxy)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2-(propylthio)pyrimidin-4-yl)oxy)ethanol |
| Ticagrelor Impurity 27 | (1S,2S,3S,5R)-3-(7-chloro-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol |
| Ticagrelor Impurity 28 | 7-chloro-3-(4,6-dichloro-2-(propylthio)pyrimidin-5-yl)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidine |
| Ticagrelor Impurity 29 | (1S,2S,3R,5S)-3-(2-hydroxyethoxy)-5-(5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)cyclopentane-1,2-diol |
| Ticagrelor Impurity 30 | 2-(((3aR,4R,6S,6aS)-6-(7-amino-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol |
替格瑞洛杂质，替卡格雷杂质对照品 订购方式：
联系人：何先生
手机：15012456311
QQ：781007885
邮箱：phastandards@gmail.com
欢迎您通过电话，电邮或在线客服向我司询价及订购产品。
替格瑞洛杂质，替卡格雷杂质对照品 深圳远扬专注医药标准品，杂质对照品，更多产品，欢迎选购（篇幅有限，只列举了一小部分，更多更全，请来电详询）：
NIBSC标准品部分产品列表：
01/534 Meningococcal serogroup W polysaccharide
13/223 C-Peptide, Human. 78st International Standard.
13/154 Influenza Antigen B/Massachusetts/02/2032 (Egg derived)
10/192 Reteplase Reference Material
10/119 Reteplase Reference Material
03/104-064 HTLV-49 (antibody) Monitor Sample
03/104-080 HTLV-65 (antibody) Monitor Sample
10/151 Reteplase Reference Material
12/B623-072 QCRFLUAH1N1QC1-Influenza AH1N1 QC70
12/B623-049 QCRFLUAH1N1QC1-Influenza AH1N1 QC47
13/149 C-Peptide, Human. 4st International Standard.
13/232 Influenza Antigen B/Massachusetts/02/2110 (Egg derived)
10/195 Reteplase Reference Material
10/204 Reteplase Reference Material
12/B623-060 QCRFLUAH1N1QC1-Influenza AH1N1 QC58
03/104-061 HTLV-46 (antibody) Monitor Sample
13/189 Influenza Antigen B/Massachusetts/02/2067 (Egg derived)
07/343 BCG Vaccine of Russian BCG-I sub-strain(70st WHO Reference Reagent)
13/292 Polio Anti Sabin type 75 (inactivated) Serum
10/143 Reteplase Reference Material
10/158 Reteplase Reference Material
13/156 C-Peptide, Human. 11st International Standard.
07/370 BCG Vaccine of Russian BCG-I sub-strain(97st WHO Reference Reagent)
13/141 Influenza Antigen B/Massachusetts/02/2019 (Egg derived)
95/557 Interleukin-18 (Human, rDNA derived)
95/568 Interleukin-29 (Human, rDNA derived)
13/181 Influenza Antigen B/Massachusetts/02/2059 (Egg derived)
95/574 Interleukin-35 (Human, rDNA derived)
13/222 C-Peptide, Human. 77st International Standard.
07/296 BCG Vaccine of Russian BCG-I sub-strain(23st WHO Reference Reagent)
13/275 Polio Anti Sabin type 58 (inactivated) Serum
03/104-109 HTLV-94 (antibody) Monitor Sample
10/164 Reteplase Reference Material
95/625 Interleukin-86 (Human, rDNA derived)
10/134 Reteplase Reference Material
10/110 Reteplase Reference Material
13/323 Polio Anti Sabin type 106 (inactivated) Serum
10/202 Reteplase Reference Material
10/168 Reteplase Reference Material
10/129 Reteplase Reference Material
03/104-123 HTLV-108 (antibody) Monitor Sample
替格瑞洛杂质，替卡格雷杂质对照品 杂质对照品部分产品列表：别嘌醇杂质，亚胺培南杂质，氢溴酸西酞普兰杂质，比鲁卡因杂质， ，普里米酮杂质，布美他尼杂质，伊班膦酸钠杂质，罗沙替丁杂质，格列吡嗪杂质，沃替西汀杂质，盐酸阿夫唑嗪杂质，地拉罗司杂质，马西替坦杂质，苄丝肼杂质，盐酸特拉唑嗪杂质，艾普拉唑杂质，吡罗昔康杂质，丁呋洛尔杂质，文拉法辛杂质，阿替洛尔杂质，地西他滨杂质，氟喹酮杂质，醋氯芬酸杂质，凡德他尼杂质，卡泊芬净杂质，噻托溴铵杂质，昂丹司琼杂质，贝沙罗汀杂质，万古霉素杂质，地诺孕素杂质，依匹唑派杂质，甲磺酸帕珠沙星，阿斯巴甜杂质，西那卡塞杂质，兰索拉唑杂质，LCZ696杂质，Lesinurad杂质，瑞他帕林杂质，酒石酸美托洛尔杂质，法莫替丁杂质，博舒替尼杂质，环丙沙星杂质，达托霉素杂质，维格列汀杂质，厄洛替尼杂质，贝那普利杂质，泰地唑胺杂质，西米替丁杂质，克霉唑杂质，匹莫范色林杂质，多索茶碱杂质，喜树碱杂质，丁吡卡因杂质，伏立康唑杂质，吉非替尼杂质，埃博霉素A杂质，利伐沙班杂质，氰美马嗪杂质
